Research Articles
Unraveling Tumor Immune Evasion: How CRISPR Screens Decode the Tumor Microenvironment
This article provides a comprehensive guide to using CRISPR-based functional genomics screens to identify and validate mechanisms of immune evasion within the tumor microenvironment (TME).
Harnessing CRISPR Screens: A Comprehensive Guide to Discovering New Cancer Drug Targets
This article provides a detailed overview of CRISPR screening for cancer drug target discovery, tailored for researchers, scientists, and drug development professionals.
CRISPR Screening for Cancer Stem Cell Markers: A Comprehensive Guide for Precision Oncology
This article provides researchers and drug development professionals with a comprehensive guide to using CRISPR-based screening for identifying and validating cancer stem cell (CSC) markers.
CRISPR Base Editors vs. Prime Editors: A Comparative Guide for Cancer Mutation Correction in Research & Therapy
This article provides a comprehensive technical analysis of CRISPR base editing and prime editing platforms for the precise correction of oncogenic mutations.
CRISPR-Cas9 vs TALENs: A 2024 Comparative Analysis of Gene Editing Efficiency in Cancer Therapeutics
This comprehensive review compares the efficiency, precision, and practical application of CRISPR-Cas9 and TALENs for gene editing in cancer research and drug development.
CRISPR-Cas9 Somatic Cell Editing: Revolutionizing Cancer Modeling and Preclinical Research
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on leveraging CRISPR-Cas9 somatic cell genome editing for advanced cancer modeling.
A Complete Guide: CRISPR-Cas9 Engineering for Next-Generation CAR T-Cell Therapies
This protocol article provides a comprehensive, step-by-step guide for researchers and drug development professionals on utilizing CRISPR-Cas9 gene editing to engineer chimeric antigen receptor (CAR) T cells.
CRISPR-Cas9 and PDX Models: A Next-Generation Platform for Precision Oncology Research and Drug Development
This comprehensive article explores the integration of CRISPR-Cas9 gene-editing technology with Patient-Derived Xenograft (PDX) models, a transformative approach in cancer research.
Harnessing CRISPR-Cas9 for Cancer Epigenetics: A Comprehensive Guide to Editing, Therapy, and Clinical Translation
This article provides a detailed exploration of CRISPR-Cas9 applications in cancer epigenetics for researchers, scientists, and drug development professionals.
CD44, CD133, ALDH1: Are These the Universal Cancer Stem Cell Markers? A 2024 Research Guide
This article provides a comprehensive analysis of CD44, CD133, and ALDH1 as established markers for identifying Cancer Stem Cells (CSCs).